Braun Stacey Associates’s Alexion Pharmaceuticals ALXN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-38,262	Closed	-$5.85M	–	145
2021 Q1	$5.85M	Sell	38,262 -82,940	-68%	-$12.8M	0.25%	103
2020 Q4	$18.9M	Buy	121,202 +10,434	+9%	+$1.34M	0.85%	52
2020 Q3	$12.7M	Sell	110,768 -2,157	-2%	-$233K	0.68%	75
2020 Q2	$12.7M	Buy	112,925 +144	+0.1%	+$15.3K	0.73%	72
2020 Q1	$10.1M	Sell	112,781 -31,580	-22%	-$3.1M	0.77%	63
2019 Q4	$15.6M	Buy	144,361 +19,250	+15%	+$2.06M	0.87%	59
2019 Q3	$12.3M	Buy	125,111 +6,361	+5%	+$717K	0.77%	75
2019 Q2	$15.6M	Buy	118,750 +4,040	+4%	+$521K	1%	43
2019 Q1	$15.5M	Buy	114,710 +19,600	+21%	+$2.44M	1.03%	39
2018 Q4	$9.26M	Sell	95,110 -18,962	-17%	-$2.24M	0.73%	68
2018 Q3	$15.9M	Buy	114,072 +7,243	+7%	+$909K	1.01%	41
2018 Q2	$13.3M	Buy	106,829 +5,771	+6%	+$674K	0.9%	55
2018 Q1	$11.3M	Buy	+101,058	New	+$12.1M	0.77%	73
2015 Q3	–	Sell	-101,600	Closed	-$18.4M	–	279
2015 Q2	$18.4M	Buy	+101,600	New	+$17.5M	0.78%	56
2013 Q4	–	Sell	-2,080	Closed	-$242K	–	162
2013 Q3	$242K	Sell	2,080 -21,090	-91%	-$2.31M	0.01%	133
2013 Q2	$2.14M	Buy	+23,170	New	+$2.23M	0.13%	108